• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Timing versus duration of adjuvant therapy for pancreatic cancer: all the lessons we need in life are taught to us as children.

作者信息

Chan Emily, Berlin Jordan

机构信息

Vanderbilt University Medical Center, Nashville, TN.

出版信息

J Clin Oncol. 2014 Feb 20;32(6):487-8. doi: 10.1200/JCO.2013.53.5617. Epub 2014 Jan 13.

DOI:10.1200/JCO.2013.53.5617
PMID:24419124
Abstract
摘要

相似文献

1
Timing versus duration of adjuvant therapy for pancreatic cancer: all the lessons we need in life are taught to us as children.胰腺癌辅助治疗的时机与持续时间：我们生命中所需的所有教训在孩童时期就已传授给我们。
J Clin Oncol. 2014 Feb 20;32(6):487-8. doi: 10.1200/JCO.2013.53.5617. Epub 2014 Jan 13.
2
[Optimal duration and timing of adjuvant chemotherapy after resection for pancreatic ductal adenocarcinoma].[胰腺导管腺癌切除术后辅助化疗的最佳持续时间和时机]
Chirurg. 2014 Jun;85(6):543. doi: 10.1007/s00104-014-2779-x.
3
[I. The Efficacy of Preoperative Adjuvant Treatment for Pancreatic Ductal Adenocarcinoma Based on the Resectability Criteria according to JPS 7th].[I. 基于日本胰腺学会（JPS）第7版可切除性标准的胰腺导管腺癌术前辅助治疗的疗效]
Gan To Kagaku Ryoho. 2017 Oct;44(10):837-844.
4
Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy.精准肿瘤学在胰腺癌中的应用：从手术到基于遗传的化疗。
Rev Invest Clin. 2020 Dec 22;72(6):333-336. doi: 10.24875/RIC.20000233.
5
Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.术后血清白蛋白水平是胰腺导管腺癌患者辅助化疗不完整的一个标志物。
Ann Surg Oncol. 2015 Jul;22(7):2408-15. doi: 10.1245/s10434-014-4280-7. Epub 2014 Dec 9.
6
Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma in Elderly Patients: Special Reference to Postoperative Adjuvant Chemotherapy.老年患者胰腺导管腺癌胰十二指肠切除术后的长期预后：特别提及术后辅助化疗
World J Surg. 2018 Aug;42(8):2617-2626. doi: 10.1007/s00268-018-4496-y.
7
Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".关于《术后化疗对接受术前治疗和胰腺癌胰十二指肠切除术患者有益》的评论
Ann Surg. 2021 Dec 1;274(6):e718. doi: 10.1097/SLA.0000000000003989.
8
Response to the Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".对《术后化疗对接受术前治疗及胰腺切除术的胰腺腺癌患者有益》一文评论的回应
Ann Surg. 2021 Dec 1;274(6):e718-e719. doi: 10.1097/SLA.0000000000003987.
9
Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference?胰腺切除术的时机与患者预后：有差异吗？
Surg Clin North Am. 2018 Feb;98(1):57-71. doi: 10.1016/j.suc.2017.09.006.
10
Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.局部晚期导管腺癌放化疗后的胰腺切除术：围手术期结局与生存分析
Ann Surg Oncol. 2006 Sep;13(9):1201-8. doi: 10.1245/s10434-006-9032-x. Epub 2006 Sep 6.

引用本文的文献

1
The Yonsei criteria as a clinically detectable parameter for excellent prognosis in resected left-sided pancreatic cancer: outcomes of a propensity score-matched analysis.Yonsei 标准作为可临床检测的左胰腺癌切除术后预后良好的参数：倾向评分匹配分析的结果。
Surg Endosc. 2017 Nov;31(11):4656-4664. doi: 10.1007/s00464-017-5529-6. Epub 2017 Apr 7.
2
GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma.谷草转氨酶1/天冬氨酸氨基转移酶1表达状态作为胰腺导管腺癌的一种预后生物标志物
Oncotarget. 2015 Feb 28;6(6):4516-26. doi: 10.18632/oncotarget.2799.